Literature DB >> 21422740

Green tea polyphenol sensing.

Hirofumi Tachibana1.   

Abstract

Green tea polyphenols have emerged over the past two decades as an important dietary factor for health promotion. There is considerable evidence that tea polyphenols, in particular (-)-epigallocatechin-3-gallate (EGCG) inhibit carcinogenesis. However, the mechanisms for the cancer-preventive activity of EGCG are not completely characterized and many features remain to be elucidated. Recently we have identified a cell-surface EGCG receptor and the relating molecules that confer EGCG responsiveness to many cancer cells at physiological concentrations. Here, we review some of the reported mechanisms for the cancer chemopreventive action of EGCG and provide an overview of several molecules that sense and manage the physiological functions of EGCG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422740      PMCID: PMC3066547          DOI: 10.2183/pjab.87.66

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  91 in total

1.  Identification of a methylated tea catechin as an inhibitor of degranulation in human basophilic KU812 cells.

Authors:  H Tachibana; Y Sunada; T Miyase; M Sano; M Maeda-Yamamoto; K Yamada
Journal:  Biosci Biotechnol Biochem       Date:  2000-02       Impact factor: 2.043

2.  Circular ruffle formation in rat basophilic leukemia cells in response to antigen stimulation.

Authors:  A J Edgar; J P Bennett
Journal:  Eur J Cell Biol       Date:  1997-06       Impact factor: 4.492

3.  Formation of the 67-kDa laminin receptor by acylation of the precursor.

Authors:  S Butò; E Tagliabue; E Ardini; A Magnifico; C Ghirelli; F van den Brûle; V Castronovo; M I Colnaghi; M E Sobel; S Ménard
Journal:  J Cell Biochem       Date:  1998-06-01       Impact factor: 4.429

4.  Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

Authors:  Masood A Shammas; Paola Neri; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Vidit Munshi; Rao Prabhala; Mariateresa Fulciniti; Yu Tzu Tai; Steven P Treon; Raj K Goyal; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

5.  Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.

Authors:  Ming Li; Zhiwei He; Svetlana Ermakova; Duo Zheng; Faqing Tang; Yong-Yeon Cho; Feng Zhu; Wei-Ya Ma; Yuk Sham; Evgeny A Rogozin; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

6.  (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.

Authors:  Svetlana P Ermakova; Bong Seok Kang; Bu Young Choi; Hong Seok Choi; Todd F Schuster; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

7.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

8.  Elongation factor-1 alpha is a novel substrate of rho-associated kinase.

Authors:  T Izawa; Y Fukata; T Kimura; A Iwamatsu; K Dohi; K Kaibuchi
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

9.  Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.

Authors:  Jungil Hong; Hong Lu; Xiaofeng Meng; Jae-Ha Ryu; Yukihiko Hara; Chung S Yang
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

Review 10.  Tea polyphenols for health promotion.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Life Sci       Date:  2007-06-28       Impact factor: 5.037

View more
  27 in total

1.  Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 2.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

Review 3.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 4.  Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.

Authors:  Beatrix Peter; Szilvia Bosze; Robert Horvath
Journal:  Eur Biophys J       Date:  2016-06-16       Impact factor: 1.733

Review 5.  Health-promoting effects of green tea.

Authors:  Yasuo Suzuki; Noriyuki Miyoshi; Mamoru Isemura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

6.  Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects.

Authors:  Mariangela Rondanelli; Annalisa Opizzi; Simone Perna; Milena Faliva; Sebastiano Bruno Solerte; Marisa Fioravanti; Catherine Klersy; Edda Cava; Cava Edda; Maddalena Paolini; Paolini Maddalena; Luciano Scavone; Scavone Luciano; Paola Ceccarelli; Ceccarelli Paola; Emanuela Castellaneta; Castellaneta Emanuela; Claudia Savina; Savina Claudia; Lorenzo Maria Donini
Journal:  Endocrine       Date:  2012-12-28       Impact factor: 3.633

7.  Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model.

Authors:  Cornelia Braicu; Valentina Pileczki; Laura Pop; Roxana Cojocneanu Petric; Sergiu Chira; Eve Pointiere; Patriciu Achimas-Cadariu; Ioana Berindan-Neagoe
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

8.  Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells.

Authors:  Yuhui Huang; Motofumi Kumazoe; Jaehoon Bae; Shuhei Yamada; Mika Takai; Shiori Hidaka; Shuya Yamashita; Yoonhee Kim; Yeongseon Won; Motoki Murata; Shuntaro Tsukamoto; Hirofumi Tachibana
Journal:  Oncol Rep       Date:  2015-06-26       Impact factor: 3.906

9.  Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet.

Authors:  Aline B Santamarina; Juliana L Oliveira; Fernanda P Silva; June Carnier; Laís V Mennitti; Aline A Santana; Gabriel H I de Souza; Eliane B Ribeiro; Cláudia M Oller do Nascimento; Fábio S Lira; Lila M Oyama
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  Catechins and antitumor immunity: Not MDSC's cup of tea.

Authors:  Giorgia Santilli; John Anderson; Adrian J Thrasher; Arturo Sala
Journal:  Oncoimmunology       Date:  2013-05-08       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.